United States - English - NLM (National Library of Medicine)

american regent, inc. - zinc sulfate heptahydrate (unii: n57ji2k7wp) (zinc cation - unii:13s1s8sf37), cupric sulfate (unii: lrx7aj16dt) (cupric cation - unii:8cbv67279l), manganese sulfate (unii: w00lys4t26) (manganese cation (2+) - unii:h6ep7w5457), chromic chloride (unii: kb1pcr9dmw) (chromic cation - unii:x1n4508kf1) - zinc cation 4.39 mg in 1 ml - this formulation is indicated for use as a supplement to intravenous solutions given for tpn for children up to 11 years of age. administration of the solution in tpn solutions helps to maintain plasma levels of zinc, copper, manganese, and chromium and to prevent depletion of endogenous stores of these trace elements and subsequent deficiency symptoms. multitrace ® - 4 pediatric should not be given undiluted by direct injection into a peripheral vein because of the potential of infusion phlebitis.

United States - English - NLM (National Library of Medicine)

american regent, inc. - zinc sulfate heptahydrate (unii: n57ji2k7wp) (zinc cation - unii:13s1s8sf37), cupric sulfate (unii: lrx7aj16dt) (cupric cation - unii:8cbv67279l), manganese sulfate (unii: w00lys4t26) (manganese cation (2+) - unii:h6ep7w5457), chromic chloride (unii: kb1pcr9dmw) (chromic cation - unii:x1n4508kf1) - zinc cation 6.6 mg in 1 ml - multitrace ® - 4 neonatal is indicated for use as a supplement to intravenous solutions given for tpn. administration of multitrace ® - 4 neonatal in tpn solutions helps to maintain plasma levels of zinc, copper, manganese, and chromium and to prevent depletion of endogenous stores of these trace elements and subsequent deficiency symptoms. multitrace ® - 4 neonatal should not be given undiluted by direct injection into a peripheral vein because of the potential of infusion phlebitis.

United States - English - NLM (National Library of Medicine)

american regent, inc. - zinc sulfate heptahydrate (unii: n57ji2k7wp) (zinc cation - unii:13s1s8sf37), cupric sulfate (unii: lrx7aj16dt) (cupric cation - unii:8cbv67279l), manganese sulfate (unii: w00lys4t26) (manganese cation (2+) - unii:h6ep7w5457), chromic chloride (unii: kb1pcr9dmw) (chromic cation - unii:x1n4508kf1) - zinc cation 2.2 mg in 1 ml - this formulation is indicated for use as a supplement to intravenous solutions given for tpn for children up to 11 years of age. administration of the solution in tpn solutions helps to maintain plasma levels of zinc, copper, manganese, and chromium and to prevent depletion of endogenous stores of these trace elements and subsequent deficiency symptoms. trace elements injection 4, usp pediatric should not be given undiluted by direct injection into a peripheral vein because of the potential of infusion phlebitis.

United States - English - NLM (National Library of Medicine)

american regent, inc. - zinc sulfate heptahydrate (unii: n57ji2k7wp) (zinc cation - unii:13s1s8sf37), cupric sulfate (unii: lrx7aj16dt) (cupric cation - unii:8cbv67279l), manganese sulfate (unii: w00lys4t26) (manganese cation (2+) - unii:h6ep7w5457), chromic chloride (unii: kb1pcr9dmw) (chromic cation - unii:x1n4508kf1) - zinc cation 4.39 mg in 1 ml - this formulation is indicated for use as a supplement to intravenous solutions given for tpn. administration of the solution in tpn solutions helps to maintain plasma levels of zinc, copper, manganese, and chromium and to prevent depletion of endogenous stores of these trace elements and subsequent deficiency symptoms. multitrace ® - 4 should not be given undiluted by direct injection into a peripheral vein because of the potential of infusion phlebitis. warnings: copper and manganese are eliminated via the bile. in patients with severe liver dysfunction and/or biliary tract obstruction, decreasing or omitting copper and manganese supplements entirely may be necessary. this product contains aluminum that may be toxic. aluminum may reach toxic levels with prolonged parenteral administration if kidney function is impaired. premature neonates are particularly at risk because their kidneys are immature, and they require large amounts of calcium and phosphate solutions, which contain aluminum. research indicate

United States - English - NLM (National Library of Medicine)

american regent, inc. - zinc sulfate heptahydrate (unii: n57ji2k7wp) (zinc cation - unii:13s1s8sf37), cupric sulfate (unii: lrx7aj16dt) (cupric cation - unii:8cbv67279l), manganese sulfate (unii: w00lys4t26) (manganese cation (2+) - unii:h6ep7w5457), chromic chloride (unii: kb1pcr9dmw) (chromic cation - unii:x1n4508kf1), selenious acid (unii: f6a27p4q4r) (selenious acid - unii:f6a27p4q4r) - zinc cation 4.39 mg in 1 ml - this formulation is indicated for use as a supplement to intravenous solutions given for tpn. administration of the solution in tpn solutions helps to maintain plasma levels of zinc, copper, manganese, selenium and chromium and to prevent depletion of endogenous stores of these trace elements and subsequent deficiency symptoms. multitrace ® - 5 should not be given undiluted by direct injection into a peripheral vein because of the potential of infusion phlebitis.

United States - English - NLM (National Library of Medicine)

american regent, inc. - zinc sulfate heptahydrate (unii: n57ji2k7wp) (zinc cation - unii:13s1s8sf37), cupric sulfate (unii: lrx7aj16dt) (cupric cation - unii:8cbv67279l), manganese sulfate (unii: w00lys4t26) (manganese cation (2+) - unii:h6ep7w5457), chromic chloride (unii: kb1pcr9dmw) (chromic cation - unii:x1n4508kf1), selenious acid (unii: f6a27p4q4r) (selenious acid - unii:f6a27p4q4r) - zinc cation 22 mg in 1 ml - this formulation is indicated for use as a supplement to intravenous solutions given for tpn. administration of the solution in tpn solutions helps to maintain plasma levels of zinc, copper, manganese, selenium and chromium and to prevent depletion of endogenous stores of these trace elements and subsequent deficiency symptoms. multitrace® - 5 concentrate should not be given undiluted by direct injection into a peripheral vein because of the potential of infusion phlebitis.

United States - English - NLM (National Library of Medicine)

nature&bio co., ltd. - zinc oxide (unii: soi2loh54z) (zinc cation - unii:13s1s8sf37) - zinc cation 2.14 g in 12 g

United States - English - NLM (National Library of Medicine)

nature&bio co., ltd. - zinc oxide (unii: soi2loh54z) (zinc cation - unii:13s1s8sf37) - zinc cation 0.53 g in 3 g

United States - English - NLM (National Library of Medicine)

naterra international inc. - zinc oxide (unii: soi2loh54z) (zinc oxide - unii:soi2loh54z) - zinc oxide 23.8 g in 85 g - uses: helps treat and prevent diaper rash , chaged skin and minor skin irritation by protecting and ealing out wetness. direction change wet and soiled diapers promptly; cleanse diaper area and allow to dry apply product liberally with each diaper change and expecially at bedtime when exposure to wet diapers may be prolonged

United States - English - NLM (National Library of Medicine)

pd-rx pharmaceuticals, inc. - citalopram hydrobromide (unii: i1e9d14f36) (citalopram - unii:0dhu5b8d6v) - citalopram tablets are indicated for the treatment of depression. the efficacy of citalopram tablets in the treatment of depression was established in 4 to 6 week, controlled trials of outpatients whose diagnosis corresponded most closely to the dsm-iii and dsm-iii-r category of major depressive disorder (see clinical pharmacology ). a major depressive episode (dsm-iv) implies a prominent and relatively persistent (nearly every day for at least 2 weeks) depressed or dysphoric mood that usually interferes with daily functioning, and includes at least five of the following nine symptoms: depressed mood, loss of interest in usual activities, significant change in weight and/or appetite, insomnia or hypersomnia, psychomotor agitation or retardation, increased fatigue, feelings of guilt or worthlessness, slowed thinking or impaired concentration, a suicide attempt or suicidal ideation. the antidepressant action of citalopram tablets in hospitalized depressed patients has not been adequately studied. t